Flor-Lorente B, Noguer-Aguilar JF, Delgado-Rivilla S, García-González JM, Rodriguez-Martín M, Salinas-Ortega L, Casado MA, Álvarez M
The economic impact of anastomotic leak after colorectal cancer surgery
Health Econ Rev 13, 12 (2023)
Presa M, Vicente D, Calles A, Salinas-Ortega L, Naik J, García LF, Soto J
Lorlatinib as a first-line treatment for ALK+ advanced Non-Small Cell Lung Cancer: a cost-effectiveness analysis in Spain
25th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena (Austria). 06-09 nov 2022
Alonso JC, Casans I, González FM, Fuster D, Rodríguez A, Sánchez N, Oyagüez I, Burgos R, Williams AO, Espinoza N
Economic evaluations of radioembolization with itrium-90 microspheres in hepatocellular carcinoma: a systematic review
BMC Gastroenterol. 2022 Jul 2;22(1):326
Williams A, Alonso-Farto JC, Casáns-Tormo I, Rodríguez-Fernández A, Fuster D, Sánchez-Izquierdo N, Gonzalez-Garcia F, Espinoza-Cámac N, Burgos-Pol R, Agreda G, White R, Fueyo A, Oyagüez I
A systematic literature review of the economic evidence for transarterial radioembolization for the treatment of hepatocellular carcinoma
Annual Meeting -American Society of Clinical Oncology 2022. Chicago (Illinois-USA). 3-7 jun 2022
Rubio AR, Mareque M, Soto J, Casado MA, Alvarez R, Andrade J, Esteban C, Chacón JI
Patient-reported experience in lung and breast cancer through a patient journey
Farmacia Hospitalaria 2022; 46(4):215-23
Calleja MA, Albanell J, Aranda E, García-Foncillas J, Feliu A, Rivera F, Oyagüez I, Salinas-Ortega L, Soto J
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain
Eur J Hosp Pharm. doi:10.1136/ejhpharm-2021-002955
Cassinello J, Dominguez-Lubillo T, Gómez-Barrera M, Hernando T, Parra R, Asensio I, Casado MA, Moreno P
Optimal Treatment Sequencing of Abiraterone Acetate Plus Prednisone and Enzalutamide in Patients with Castration-Resistant Metastatic Prostate Cancer: a Systematic Review and Meta-Analysis
Cancer Treat Rev. 2021;93:102152. doi: 10.1016/j.ctrv.2020.102152
Rubio-Salvador, AR, Escudero-Vilaplana, V, Marcos Rodríguez, JA, Mangues-Bafalluy, I, Bernardez, B, García Collado, C, Collado-Borrell, R, Alvarado Fernández, M.D, Chacón López-Muñiz, JI, Yébenes Cortés, M, Gómez Barrera, M, Calleja-Hernández, MA
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: Costecat Study
Int. J. Environ. Res. Public Health 2021, 18, 394
Rodríguez Lescure Á, Pérez JM, Martín M, López R, de la Cruz L, Ciruelos E, Albanell J, Yébenes M